A child was denied medication for a condition her own insurance company admitted would have been covered, had she simply not been transgender.

That is the core of this case. Blue Cross Blue Shield of Illinois developed a documented, systematic process to locate and deny claims from transgender patients. They offered pre-written exclusion language to employers who wanted to cut trans patients off from care. They processed those denials through an automated internal system. They never asked employers for a reason. They would have carried out the denials even if the employer’s motivation was openly discriminatory. A federal appeals court has now confirmed that this constitutes intentional sex-based discrimination under federal law.

This is a class action lawsuit, which means the harm extended to every person enrolled in any of the 398 BCBSIL-administered employer health plans that carried a gender-affirming care exclusion during the class period, which runs from November 23, 2016 to the present. These are not hypothetical patients. They are workers and their children who paid for health insurance and were systematically cut off from medically necessary care.

The Assembly Line of Denial: How BCBSIL Built It

Blue Cross Blue Shield of Illinois does not just sell insurance. It also functions as a “third-party administrator,” meaning companies hire it to process and pay out claims on their behalf. This arrangement gave BCBSIL enormous power over what care workers could actually receive. And BCBSIL used that power to build a streamlined denial machine for transgender patients.

According to the court record, BCBSIL gave employers who wanted to exclude gender-affirming care a ready-made solution: standardized exclusion language. Of the 398 employer clients who chose to exclude gender-affirming care, 378 used the exact boilerplate text that BCBSIL handed them. The company did not require any justification, medical or otherwise. It did not ask whether the employer had a religious reason, a cost reason, or any reason at all. It would administer the denial even if it knew the employer’s motivation was pure discrimination.

BCBSIL’s internal process for handling these denied claims was not a case-by-case medical judgment. It was a lookup table. A corporate representative testified under oath that BCBSIL’s standard practice was to “look at the diagnosis and service code to determine if it’s gender reassignment, and if it is then it is denied.” That is the full extent of the medical review for thousands of patients.

They Knew the Care Was Medically Necessary. They Denied It Anyway.

Here is the fact that demolishes any good-faith argument BCBSIL might make: for its fully-insured plans, the company covers gender-affirming care. The court document states plainly that BCBSIL considers these treatments to be medically necessary for adolescents with gender dysphoria. BCBSIL itself acknowledged this in court. So the company was simultaneously: telling some patients that their gender-affirming care is medically necessary and covering it, while telling other patients that the exact same care is categorically excluded and therefore denied. The only difference between those two groups of patients was which type of employer plan they were enrolled in.

The appeals court seized on this contradiction directly, noting that “because BCBSIL admits those treatments are sometimes necessary, it cannot justify its categorical exclusion by citing medical necessity. Something else may be afoot, and that something may be invidious discrimination against transgender people.”

The People Behind the Case Numbers

C.P. is a young transgender man diagnosed with gender dysphoria. His plan, administered by BCBSIL on behalf of Catholic Health Initiatives, excluded treatment for gender dysphoria for religious reasons. His doctor prescribed puberty-delaying medication delivered through a Vantas implant. BCBSIL initially covered it, then reversed course, calling it a coverage error. The family appealed. The appeal was denied. When C.P. needed a second implant, BCBSIL denied it from the start. His doctor also recommended gender-affirming chest surgery. BCBSIL denied that too. A BCBSIL representative acknowledged on record that the surgery was medically necessary. They denied it anyway.

Emmett Jones is a transgender man enrolled in the same plan as C.P. His providers recommended gender-affirming chest surgery. Knowing coverage would be denied, Jones paid entirely out of pocket and then sought reimbursement from BCBSIL. The reimbursement was denied.

S.L.’s case is the most damning. She is a transgender girl diagnosed with both gender dysphoria and precocious puberty, which is a medical condition where puberty begins at an abnormally young age. Her healthcare provider prescribed puberty-blocking hormones to treat the precocious puberty. BCBSIL denied coverage under the trans care exclusion. During the appeals process, S.L.’s mother was told directly by BCBSIL membership services staff that if S.L. had only been diagnosed with early-onset puberty and not gender dysphoria, the puberty blocker would likely have been covered. In other words: the same medication, treating the same condition, was available to every other child with that condition, except the one who happened to also be transgender.

The Non-Financial Ledger: What a Denial Actually Costs a Person

When a health insurance company denies a claim, they send a letter. It is called an Explanation of Benefits. It arrives in the mail, or in an inbox, and it says some version of “your claim has been denied.” For most people, most of the time, that means a bill they did not expect. For transgender patients denied gender-affirming care, it means something much deeper and far more lasting than a dollar figure.

Gender dysphoria, as defined by the American Psychiatric Association and confirmed in this court record, is a condition where the disconnect between a person’s experienced gender and their assigned sex at birth causes “clinically significant distress or impairment in social, occupational, or other important areas of functioning.” The court document is explicit: without treatment, gender dysphoria can lead to anxiety, depression, and suicide. This is not a hypothetical risk. This is documented medical consensus. When BCBSIL denied coverage to C.P., to S.L., to Emmett Jones, and to every member of this class, it denied treatment for a condition that, left untreated, statistically kills people.

Consider what it means for a family to receive a denial for a child’s puberty blocker. The medication exists. The doctor has prescribed it. The insurance card is in the parent’s wallet. And then a letter arrives saying the company will not pay, citing an exclusion that applies specifically because their child is transgender. That parent now faces a choice that no parent of a non-transgender child with precocious puberty ever has to face: go into debt to pay out of pocket, or watch their child go through a puberty that causes documented psychological harm. BCBSIL made that choice for thousands of families. It made it without asking for a single medical justification from the employer who requested the exclusion.

Emmett Jones paid for his own surgery. He paid out of pocket. He then filed for reimbursement through the insurance he was paying premiums on every month, and was denied. That is the texture of what this system does to people: it takes their money in premiums, excludes them from benefits based on who they are, and forces them to pay twice for the same care that their non-transgender coworkers receive for free. The psychological weight of that kind of institutional rejection, repeated at every stage of the appeals process, is a form of harm the legal system has not yet found an adequate dollar value for. But the harm is real, and it is documented in this record.

Legal Receipts: Their Own Words Bury Them

“BCBSIL never asks employers for a justification or reason when they exclude gender-affirming care. It does not require a medical, scientific, or religious reason for the exclusions. It would administer the exclusion even if the employer wanted the exclusion for discriminatory purposes.” — U.S. Ninth Circuit Court of Appeals, Pritchard v. BCBSIL (2025), describing BCBSIL’s undisputed company policy

“BCBSIL had a ‘standard practice’ for these claims: ‘look at the diagnosis and service code to determine if it’s gender reassignment, and if it is then it is denied.'” — Ninth Circuit Opinion, quoting BCBSIL’s own corporate representative under oath

“S.L.’s mother ‘was told by BCBSIL membership services that, had S.L. been diagnosed only with early-onset puberty (i.e., not gender dysphoria AND early-onset puberty), BCBSIL would have likely covered the puberty blocker.'” — Ninth Circuit Opinion, describing BCBSIL’s own statements to S.L.’s mother during the appeals process

“Because BCBSIL admits those treatments are sometimes necessary, it cannot justify its categorical exclusion by citing medical necessity. Something else may be afoot, and that something may be invidious discrimination against transgender people.” — Ninth Circuit Opinion, identifying the logical collapse of BCBSIL’s medical necessity defense

“A BCBSIL representative stated that the surgery was necessary.” [Context: This statement was made about C.P.’s gender-affirming chest surgery. BCBSIL then denied coverage for that same surgery.] — Ninth Circuit Opinion, describing BCBSIL’s internal assessment versus its coverage decision for plaintiff C.P.

Societal Impact: Who Else Gets Hurt When Healthcare Is a Weapon

Public Health: Withholding Treatment From a Vulnerable Population

The court document is unambiguous about what untreated gender dysphoria does to people. The American Psychiatric Association recognizes gender dysphoria as a condition that, when untreated, can cause anxiety, depression, and suicide. This is the medical backdrop against which BCBSIL chose to build an automated denial system. Every claim that was auto-denied because a diagnosis code matched “gender reassignment” was a denial of treatment for a condition with documented lethal consequences if left unaddressed.

The class period runs from November 23, 2016 to the present. That means this system has been actively operating for the better part of a decade. The court certified the class to include all individuals who were denied pre-authorization or coverage solely based on a gender-affirming care exclusion across all 398 BCBSIL-administered employer plans that carried such exclusions. This is a population-level public health failure, administered claim by claim through a corporate lookup table.

The case of S.L. demonstrates the compounding medical harm most clearly. She was prescribed puberty blockers by a healthcare provider to treat precocious puberty, a documented pediatric medical condition. The denial of that medication did not just fail to address her gender dysphoria. It also potentially failed to treat her precocious puberty. One insurance exclusion, applied through BCBSIL’s automated system, simultaneously denied care for two distinct medical conditions in one child. That is the cascading effect of categorical exclusions written around transgender identity rather than around medical evidence.

Economic Inequality: The “Pay Twice” System for Trans Workers

Emmett Jones paid for his surgery out of pocket and then submitted for reimbursement. His reimbursement was denied. This means he paid insurance premiums like every other employee, received no benefit from those premiums for his procedure, and then spent money again from his own savings to access care that the court record confirms was medically necessary. This is the economic mechanism of the exclusion: transgender workers subsidize coverage for everyone else while being locked out of their own benefits.

The employer-sponsored health insurance market is where most Americans get their healthcare. The court describes this plainly: most people obtain health insurance from their employer or a family member’s employer. If a person’s employer happens to be one of BCBSIL’s 398 self-insured clients that chose to exclude gender-affirming care, that person has no meaningful alternative. They cannot individually shop out of their employer’s plan. They are stuck. And BCBSIL was perfectly willing to administer that trap indefinitely, without requiring any justification from the employer, including the employer’s documented discriminatory intent.

The economic stakes extend further still. The court notes that BCBSIL receives federal financial assistance for Medicare supplemental coverage, Medicaid, Medicare Advantage, and related programs. Federal taxpayer money flows into BCBSIL. That same company then turns around and builds discrimination infrastructure for private employer clients, infrastructure that systematically strips a vulnerable population of healthcare benefits they paid for. The public underwrites BCBSIL. BCBSIL uses that stability to help employers discriminate. This is not a market failure; it is a feature of the current system.

BCBSIL’s Four Excuses. The Court Rejected Three Immediately.

BCBSIL did not go quietly. The company came into court with four legal defenses, and it is worth walking through each one, because each one reveals something about how large corporations think they can insulate themselves from accountability for discrimination.

Excuse One: “We Don’t Get Federal Money for These Plans”

BCBSIL argued that only the specific plans that receive federal funding are subject to the ACA’s anti-discrimination rules, and since these employer-administered plans do not receive federal dollars, the rule does not apply. The court rejected this using what it calls an “entity-level analysis.” BCBSIL as a whole receives federal funding for Medicare, Medicaid, and related programs. Under Section 1557, if any part of BCBSIL’s health program receives federal assistance, the entire company’s health insurance operations are covered by the non-discrimination rule. The court found this interpretation required by the plain text of the statute.

Excuse Two: “We Were Just Following Orders From Employers”

This was BCBSIL’s most brazen defense. The company argued that because the exclusion language was chosen by the employer-clients, BCBSIL itself bore no liability for administering it. The court found this argument fails completely. Under ERISA, plan administrators must follow plan terms only when those terms are consistent with law. ERISA explicitly states it does not supersede other federal laws. Section 1557 is a federal law prohibiting sex discrimination. When the two conflict, ERISA yields. The court was direct: BCBSIL “accepted fiduciary duties” and cannot “flout the law on behalf of their employer-customers.” The company also had other options: it could have refused to administer discriminatory plans, paid denied claims from its own pocket, or sought a court ruling on the legality of the exclusions before implementing them. It chose none of those options.

Excuse Three: “Religious Freedom Protects Us”

BCBSIL invoked the Religious Freedom Restoration Act on behalf of its religious employer-clients. The court rejected this defense on two independent grounds. First, BCBSIL is a secular company. Its own religious exercise was not burdened by covering gender-affirming care, since it already covers that care for non-self-funded plans. Under RFRA, only a person whose religious exercise is actually burdened can raise the defense. BCBSIL’s is not. Second, RFRA does not apply to lawsuits between private parties where the government is not involved. This is a suit between patients and an insurance administrator. RFRA has no role here.

Excuse Four: “Our Exclusions Aren’t Sex Discrimination” — The Messy One

This is the defense that sent the case back to the lower court. The original trial court found that discriminating against gender dysphoria treatment is, by definition, sex discrimination. The appeals court agreed with the outcome but found that a recent Supreme Court ruling in an unrelated case (United States v. Skrmetti) changed the legal framework for how that conclusion must be reached. The case was sent back down to be reconsidered using the updated framework. Critically, the appeals court identified two specific arguments that could still survive under the new rules: the S.L. situation, where a patient with a non-transgender qualifying diagnosis was still denied, and the pretext argument, where BCBSIL’s categorical exclusions may be a cover for discrimination it cannot otherwise justify. The fight is not over. But the protections for transgender patients remain suspended while the legal battle continues.

The Cost of a Life: What BCBSIL Saved on Denial

What Now? The Case Isn’t Over. Neither Is the Fight.

The legal battle returns to the trial court, where new arguments will be tested against the updated Supreme Court framework. The injunction that had temporarily stopped BCBSIL from enforcing the exclusions was stayed during the appeal. That means the exclusions may still be actively in force while the case continues. Here is what to watch and what to do.

Watch These Entities

• Department of Health and Human Services (HHS) / Office for Civil Rights (OCR): HHS is the primary federal enforcement body for Section 1557. Its regulatory stance has changed multiple times across administrations. Track any new rulemaking on who qualifies as a “covered entity” under the ACA anti-discrimination rules.
• Blue Cross Blue Shield of Illinois (BCBSIL) / Health Care Services Corporation (HCSC): HCSC is BCBSIL’s parent company and signed the original agreement to abide by Section 1557. Neither has faced final liability yet. Their next legal filings in the district court on remand are the documents to demand.
• The 398 Employer-Clients: These are the companies that chose the exclusions. The court identified the Department of Labor’s ERISA enforcement arm and HHS as the agencies best positioned to target employers directly for discriminatory plan design. Press your elected representatives to demand those agencies use that power.
• Lambda Legal Defense and Education Fund: This is the organization that brought the case on behalf of the plaintiffs. They are the ones who will continue fighting this in the district court on remand. Their work directly determined that this case is still alive at all.
• Alliance Defending Freedom and the Catholic Benefits Association: These organizations filed briefs supporting BCBSIL and arguing for religious exemptions to non-discrimination requirements. They will continue to push for carve-outs that could let any employer deny any benefit under a religious framing. Know their names.

What People Can Do Right Now

If you or someone you know is enrolled in a self-insured employer health plan and has been denied gender-affirming care, contact Lambda Legal, the ACLU, or the Transgender Legal Defense and Education Fund, all of which filed briefs in this case and have resources for affected individuals. At the grassroots level, mutual aid organizations serving transgender communities have been filling the gaps left by insurance denials for years: organizations like Trans Lifeline, the Transgender Law Center, and local LGBTQ+ community centers often have emergency funds and care navigation resources. Organize inside your workplace. If your employer is self-insured, your HR department and your employer’s benefits committee made the decision about what to include in your plan. That is a decision that can be reversed through sustained worker pressure. Demand your employer’s full summary plan description in writing and read every exclusion. You have the legal right to that document. Use it.